Cargando…

Association of MMP-9 polymorphisms with diabetic nephropathy risk: A protocol for systematic review and meta-analysis

BACKGROUND: Diabetic nephropathy (DN) is a multifactorial disease with gene–environment interaction resulting in progressive renal function damage. Multiple studies have assessed the association between matrix metalloproteinase-9 (MMP-9) gene promoter polymorphism and DN susceptibility. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Yan, Wang, Zhixue, Chang, Lin, Chen, Guotao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505353/
https://www.ncbi.nlm.nih.gov/pubmed/32957381
http://dx.doi.org/10.1097/MD.0000000000022278
_version_ 1783584793042092032
author Xie, Yan
Wang, Zhixue
Chang, Lin
Chen, Guotao
author_facet Xie, Yan
Wang, Zhixue
Chang, Lin
Chen, Guotao
author_sort Xie, Yan
collection PubMed
description BACKGROUND: Diabetic nephropathy (DN) is a multifactorial disease with gene–environment interaction resulting in progressive renal function damage. Multiple studies have assessed the association between matrix metalloproteinase-9 (MMP-9) gene promoter polymorphism and DN susceptibility. However, the results are inconclusive. In the present study, we will conduct a meta-analysis to further examine this relationship more precisely. METHODS: Electronic databases (Pubmed, Web of Science, Embase, Google Scholar, Wanfang, China Biological Medicine and China National Knowledge Infrastructure) will be used to search clinical case–control studies about MMP-9 polymorphism and DN published until 18 August 2020. The language will be restricted to Chinese and English. Two reviewers will take charge of completing the selection of study, the extraction of data as well as the assessment of study quality independently. The Newcastle-Ottawa Scale will be used to evaluate the study quality. We will evaluate the association under 5 genetic models. Fixed-effects or random-effects models will be used to calculate the effect sizes of odds ratio and 95% confidence intervals. Afterwards, subgroup analysis will be conducted in terms of the ethnicity and genotyping method. Additionally, sensitivity analysis will be performed via sequentially omitting each of the included studies one at a time. The funnel plots, Egger regression test, and Begg rank correlation test will be used to test the potential publication bias. All the statistical analyses will be performed using Review Manager 5.3 and Stata 12.0. RESULTS: This protocol reported according to the Preferred Reporting ltems for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) statement. This study will provide a better understanding of the association between MMP-9 polymorphisms and DN risk. CONCLUSION: Publishing this protocol will minimize the potential bias related to data mining, thus contributing to generation of reliable evidence. OSF REGISTRATION NUMBER: DOI 10.17605/OSF.IO/H5FS4
format Online
Article
Text
id pubmed-7505353
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-75053532020-09-24 Association of MMP-9 polymorphisms with diabetic nephropathy risk: A protocol for systematic review and meta-analysis Xie, Yan Wang, Zhixue Chang, Lin Chen, Guotao Medicine (Baltimore) 5200 BACKGROUND: Diabetic nephropathy (DN) is a multifactorial disease with gene–environment interaction resulting in progressive renal function damage. Multiple studies have assessed the association between matrix metalloproteinase-9 (MMP-9) gene promoter polymorphism and DN susceptibility. However, the results are inconclusive. In the present study, we will conduct a meta-analysis to further examine this relationship more precisely. METHODS: Electronic databases (Pubmed, Web of Science, Embase, Google Scholar, Wanfang, China Biological Medicine and China National Knowledge Infrastructure) will be used to search clinical case–control studies about MMP-9 polymorphism and DN published until 18 August 2020. The language will be restricted to Chinese and English. Two reviewers will take charge of completing the selection of study, the extraction of data as well as the assessment of study quality independently. The Newcastle-Ottawa Scale will be used to evaluate the study quality. We will evaluate the association under 5 genetic models. Fixed-effects or random-effects models will be used to calculate the effect sizes of odds ratio and 95% confidence intervals. Afterwards, subgroup analysis will be conducted in terms of the ethnicity and genotyping method. Additionally, sensitivity analysis will be performed via sequentially omitting each of the included studies one at a time. The funnel plots, Egger regression test, and Begg rank correlation test will be used to test the potential publication bias. All the statistical analyses will be performed using Review Manager 5.3 and Stata 12.0. RESULTS: This protocol reported according to the Preferred Reporting ltems for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) statement. This study will provide a better understanding of the association between MMP-9 polymorphisms and DN risk. CONCLUSION: Publishing this protocol will minimize the potential bias related to data mining, thus contributing to generation of reliable evidence. OSF REGISTRATION NUMBER: DOI 10.17605/OSF.IO/H5FS4 Lippincott Williams & Wilkins 2020-09-18 /pmc/articles/PMC7505353/ /pubmed/32957381 http://dx.doi.org/10.1097/MD.0000000000022278 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle 5200
Xie, Yan
Wang, Zhixue
Chang, Lin
Chen, Guotao
Association of MMP-9 polymorphisms with diabetic nephropathy risk: A protocol for systematic review and meta-analysis
title Association of MMP-9 polymorphisms with diabetic nephropathy risk: A protocol for systematic review and meta-analysis
title_full Association of MMP-9 polymorphisms with diabetic nephropathy risk: A protocol for systematic review and meta-analysis
title_fullStr Association of MMP-9 polymorphisms with diabetic nephropathy risk: A protocol for systematic review and meta-analysis
title_full_unstemmed Association of MMP-9 polymorphisms with diabetic nephropathy risk: A protocol for systematic review and meta-analysis
title_short Association of MMP-9 polymorphisms with diabetic nephropathy risk: A protocol for systematic review and meta-analysis
title_sort association of mmp-9 polymorphisms with diabetic nephropathy risk: a protocol for systematic review and meta-analysis
topic 5200
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505353/
https://www.ncbi.nlm.nih.gov/pubmed/32957381
http://dx.doi.org/10.1097/MD.0000000000022278
work_keys_str_mv AT xieyan associationofmmp9polymorphismswithdiabeticnephropathyriskaprotocolforsystematicreviewandmetaanalysis
AT wangzhixue associationofmmp9polymorphismswithdiabeticnephropathyriskaprotocolforsystematicreviewandmetaanalysis
AT changlin associationofmmp9polymorphismswithdiabeticnephropathyriskaprotocolforsystematicreviewandmetaanalysis
AT chenguotao associationofmmp9polymorphismswithdiabeticnephropathyriskaprotocolforsystematicreviewandmetaanalysis